Tag: EACTS 2023
EACTS panel sounds call to action over sex disparities in coronary surgery
A historic underrepresentation of women in clinical trials for coronary artery bypass graft (CAB...
EACTS 2023: Registry study finds “significantly increased” all-cause mortality among older patients selected for TAVI versus SAVR
A population-based cohort study of patients treated in the Austrian healthcare system has found ...
EACTS 2023: On-X aortic valve “remains safe and effective with low dose warfarin”
Data from the On-X aortic heart valve low INR post-market study, presented during a late-breakin...
Artivion announces meaningful all-cause mortality reduction in AMDS PERSEVERE trial
Artivion has announced presentation of interim results from the Ascyrus medical dissection stent (AM...
EACTS 2023: Statin treatment may benefit SAVR patients
Ongoing statin treatment may be beneficial for patients after isolated surgical aortic valve rep...
